Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?

Marian S. Wettstein, Jasjit K. Rooprai, Clinsy Pazhepurackel, Christopher J.D. Wallis, Zachary Klaassen, Elizabeth M. Uleryk, Thomas Hermanns, Neil E. Fleshner, Alexandre R. Zlotta, Girish S. Kulkarni

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Objectives To systematically review and meta-analyze the current literature in a methodologically rigorous and transparent manner for quantitative evidence on survival outcomes among patients diagnosed with muscle-invasive bladder cancer that were treated by either trimodal therapy or radical cystectomy. Materials and methods MEDLINE, EMBASE, CENTRAL were systematically searched for comparative observational studies reporting disease-specific survival and/or overall survival on adult patients diagnosed with localized muscle-invasive bladder cancer that were exposed to either trimodal therapy or radical cystectomy. Studies qualified for meta-analysis (random effects model) if they were not at critical risk of bias (RoB). Results The literature search identified 12 eligible studies. Three (all rated as “moderate RoB”) out of 6 studies reporting on disease-specific survival qualified for quantitative analysis and yielded a pooled hazard ratio (trimodal therapy versus radical cystectomy) of 1.39 (95% confidence interval: 1.03–1.88). Four (mainly rated as “serious RoB”) out of 12 studies were included in the meta-analysis of overall survival and estimated a hazard ratio of 1.39 (1.20–1.59). Conclusion Pooled results were significant in favor of radical cystectomy. The conclusion is mainly driven by large population-based studies that are at high RoB. Hence, the certainty of these treatment estimates can be considered very low and further research will likely have an important impact on these estimates. At present, the ultimate decision between trimodal therapy and radical cystectomy should be left to the patient based on individual preferences and on the recommendation of a multidisciplinary provider team experienced with both approaches.

Original languageEnglish (US)
Article numbere0216255
JournalPloS one
Volume14
Issue number4
DOIs
StatePublished - Apr 2019

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?'. Together they form a unique fingerprint.

  • Cite this

    Wettstein, M. S., Rooprai, J. K., Pazhepurackel, C., Wallis, C. J. D., Klaassen, Z., Uleryk, E. M., Hermanns, T., Fleshner, N. E., Zlotta, A. R., & Kulkarni, G. S. (2019). Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions? PloS one, 14(4), [e0216255]. https://doi.org/10.1371/journal.pone.0216255